Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EVOLOCUMAB vs EXEMESTANE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EVOLOCUMAB vs EXEMESTANE: Safety Overview

Metric EVOLOCUMAB EXEMESTANE
Total FAERS Reports 149,666 10,418
Deaths Reported 1,723 1,256
Death Rate 1.2% 12.1%
Hospitalizations 6,890 2,327
Average Patient Age 68.1 yrs 64.2 yrs
% Female Patients 58.8% 98.7%
FDA Approval Date N/A Apr 1, 2011
Manufacturer Amgen USA Inc. Zydus Lifesciences Limited
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription